SPIONs as nano-theranostics agents / Atefeh Zarepour, Ali Zarrabi, Arezoo Khosravi.

Abbreviations; List of Figures; 1 SPIONs as Nano-Theranostics Agents; 1.1 Introduction; 1.2 Iron Oxide Nanoparticles; 1.2.1 Properties of Magnetic Nanoparticles; 1.2.1.1 Magnetic Behavior; 1.2.1.2 Size; 1.2.1.3 Charge; 1.2.1.4 Surface Functionality and Colloidal Stability; 1.2.2 Methods of Preparation; 1.2.2.1 Copercipitation; 1.2.2.2 Sol-Gel; 1.2.2.3 Thermal Decomposition; 1.2.2.4 Polyol; 1.2.2.5 Sonolysis; 1.2.2.6 Hydrothermal; 1.2.2.7 Microemulsion; 1.2.2.8 Green Synthesis; 1.2.2.9 Other Methods; 1.3 Biomedical Applications; 1.3.1 Biological Applications

1.3.1.1 Tissue Engineering1.3.1.2 Magnetic Separation; 1.3.1.3 Toxin Decorporation; 1.3.1.4 Virus and Bacterial Separation; 1.3.1.5 Protein and Nucleic Acid Separation; 1.3.1.6 Enzyme Immobilization; 1.3.1.7 Cell Labeling and Separation; 1.3.2 Theranostics and Nano-Theranostics Applications of SPIONs; 1.3.2.1 Theranostics and Nano-Theranostics; 1.3.2.2 Diagnosis; Magnetic Resonance Imaging (MRI): Principles and Applications; Multimodal Imaging; 1.3.2.3 Therapy; Hyperthermia; Drug and Gene Delivery; Targeting Approaches; Surface Functionalization; Other Therapy

1.3.2.4 SPIONs Based Nano-Theranostics for Cancer Therapy1.3.2.5 SPIONs Based Nano-Theranostics for Inflammation, Neurodegenerative and Autoimmune Disease; 1.4 Challenges and Future Prospects; References